Literature DB >> 6838370

Abdominal abscess. A surgical strategy.

P L Glick, C A Pellegrini, S Stein, L W Way.   

Abstract

To reassess the role of laparotomy and extraserosal drainage in the treatment of patients with abdominal abscess, we analyzed the course of 79 patients who underwent 97 operations to treat 120 abdominal abscesses during a five-year period. In 66 clinical episodes the abscess was drained by the most direct approach. Sepsis resolved with a single operation In 80% of these patients, five patients (8%) required a second operation for drainage for an abscess, and eight patients (12%) died. In 31 clinical episodes, the abscess was drained by a laparotomy. Sepsis resolved with a single operation in 61% of these patients, seven patients (21%) had a second abscess, six patients (19%) required a second operation to drain a metachronous abscess, and six patients (19%) died. When the location or number of abscesses was diagnosed incorrectly, the success rate of therapy fell substantially. Since most abdominal abscesses can now be accurately diagnosed preoperatively, most abscesses should be drained by a direct approach. Exploratory laparotomy is indicated when preoperative localization is unsuccessful, when sepsis has not resolved after other methods of drainage, or when the patient has a concomitant abdominal condition that must be treated surgically.

Entities:  

Mesh:

Year:  1983        PMID: 6838370     DOI: 10.1001/archsurg.1983.01390050112022

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

Review 1.  Primary psoas abscess.

Authors:  Sunita N Agrawal; Amit J Dwivedi; Mohammed Khan
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

Review 2.  Percutaneous abscess and fluid drainage: a critical review.

Authors:  R E Lambiase
Journal:  Cardiovasc Intervent Radiol       Date:  1991 May-Jun       Impact factor: 2.740

3.  Intestinal ischaemia in the unconscious intensive care unit patient.

Authors:  S Dorudi; P M Lamont
Journal:  Ann R Coll Surg Engl       Date:  1992-09       Impact factor: 1.891

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.